Theoretical, biological, and electrochemical explanation of the complexity of Peramivir’s drug–DNA interaction
Monika Wypych, Anna Ignaczak, Paulina Tokarz, Jagoda Seroka, Kamila Koszelska, Sylwia Smarzewska · 2025
Read Theoretical, biological, and electrochemical explanation of the complexity of Peramivir’s drug–DNA interaction by Monika Wypych, Anna Ignaczak, Paulina Tokarz, Jagoda Seroka, Kamila Koszelska, Sylwia Smarzewska (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12738794.txt.
Description
Monika Wypych and co-authors probe how the flu drug peramivir interacts with DNA, in a study from 2025. A drug's side dealings with DNA can shape its safety, yet this drug's were little studied. The team combined electric measures, light measures, plasmid tests, and computer models. Several forms of DNA went into the work, from full strands to single bases.
The drug was found to loosen the DNA double helix as it binds. It sits in the groove of the helix and grips the bases, with a tilt toward guanine. Computer checks confirmed the grip and the role of hydrogen bonds. The drug did not snap DNA strands, which is a point in its favor. It also gave no shield against oxidative harm. The authors say its action centers on binding, not on breaking the genome.
Catalog record
| CREATOR | Monika Wypych, Anna Ignaczak, Paulina Tokarz, Jagoda Seroka, Kamila Koszelska, Sylwia Smarzewska |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |